Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:ADME NYSEAMERICAN:AST NYSE:BCE NASDAQ:CORO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADMEAptus Drawdown Managed Equity ETF$55.77-0.7%$54.37$46.58▼$56.67$255.98M0.7915,264 shs5,239 shsASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsBCEBCE$23.81-1.0%$24.19$21.58▼$26.52$22.42B0.53.84 million shs6.07 million shsCOROiShares International Country Rotation Active ETF$36.82-0.4%$35.26$27.40▼$37.15$3.81B0.632.14 million shs1.82 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADMEAptus Drawdown Managed Equity ETF-0.69%+1.58%+0.67%+10.83%+18.27%ASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%BCEBCE-1.00%-3.09%+0.04%-7.61%+6.35%COROiShares International Country Rotation Active ETF-0.41%+3.57%+4.72%+13.99%+31.78%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADMEAptus Drawdown Managed Equity ETF$55.77-0.7%$54.37$46.58▼$56.67$255.98M0.7915,264 shs5,239 shsASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsBCEBCE$23.81-1.0%$24.19$21.58▼$26.52$22.42B0.53.84 million shs6.07 million shsCOROiShares International Country Rotation Active ETF$36.82-0.4%$35.26$27.40▼$37.15$3.81B0.632.14 million shs1.82 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADMEAptus Drawdown Managed Equity ETF-0.69%+1.58%+0.67%+10.83%+18.27%ASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%BCEBCE-1.00%-3.09%+0.04%-7.61%+6.35%COROiShares International Country Rotation Active ETF-0.41%+3.57%+4.72%+13.99%+31.78%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADMEAptus Drawdown Managed Equity ETF 2.83Moderate Buy$55.77N/AASTAsterias Biotherapeutics 0.00N/AN/AN/ABCEBCE 2.56Moderate Buy$28.6720.42% UpsideCOROiShares International Country Rotation Active ETF 2.93Moderate Buy$36.82N/ACurrent Analyst Ratings BreakdownLatest ADME, BCE, CORO, and AST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/29/2026BCEBCE Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)4/2/2026BCEBCE TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold3/17/2026BCEBCE Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$38.00 ➝ $39.00(Data available from 6/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADMEAptus Drawdown Managed Equity ETFN/AN/AN/AN/AN/AN/AASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/ABCEBCE$17.51B1.27$6.07 per share3.92$15.37 per share1.55COROiShares International Country Rotation Active ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADMEAptus Drawdown Managed Equity ETFN/AN/A25.80N/AN/AN/AN/AN/AN/AASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AN/ABCEBCE$4.62B$4.924.8412.21N/A25.66%13.87%3.33%8/6/2026 (Estimated)COROiShares International Country Rotation Active ETFN/AN/A28.57N/AN/AN/AN/AN/AN/ALatest ADME, BCE, CORO, and AST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026BCEBCE$0.42$0.46+$0.04$0.48$4.38 billion$4.43 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADMEAptus Drawdown Managed Equity ETF$0.210.38%N/AN/AN/AASTAsterias BiotherapeuticsN/AN/AN/AN/AN/ABCEBCE$1.275.34%-19.98%25.81%N/ACOROiShares International Country Rotation Active ETF$0.992.69%N/AN/AN/ALatest ADME, BCE, CORO, and AST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/7/2026BCEBCEquarterly$0.43755.2%6/15/20266/15/20267/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADMEAptus Drawdown Managed Equity ETFN/AN/AN/AASTAsterias BiotherapeuticsN/AN/AN/ABCEBCE1.840.740.71COROiShares International Country Rotation Active ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADMEAptus Drawdown Managed Equity ETFN/AASTAsterias BiotherapeuticsN/ABCEBCE41.46%COROiShares International Country Rotation Active ETFN/AInsider OwnershipCompanyInsider OwnershipADMEAptus Drawdown Managed Equity ETFN/AASTAsterias BiotherapeuticsN/ABCEBCE0.15%COROiShares International Country Rotation Active ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADMEAptus Drawdown Managed Equity ETFN/A4.59 millionN/ANot OptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableBCEBCE38,683932.53 million931.13 millionOptionableCOROiShares International Country Rotation Active ETFN/A103.56 millionN/AN/AADME, BCE, CORO, and AST HeadlinesRecent News About These CompaniesSecurity Financial Services Inc Opens iShares International Country Rotation ETF Stake Valued at $30 MillionJune 2, 2026 | fool.comCWM Opens a $521 Million Position in CORO -- What Investors Should KnowMay 22, 2026 | finance.yahoo.comThis $43 Million ETF Buy Signals Growing Confidence in Overseas StocksMay 15, 2026 | finance.yahoo.comShoreHaven Bets Big on Global Diversification With $10.3 Million CORO BuyMay 15, 2026 | finance.yahoo.comWhat to Know About This Fund’s $15 Million International ETF PurchaseMay 12, 2026 | aol.comAWhy This $5.7 Million International ETF Buy Looks Like a Bet Against U.S. Market ConcentrationMay 10, 2026 | fool.comBCGM Wealth Opens $10.07 Million Stake in BlackRock's Country-Rotation ETFMay 5, 2026 | fool.comVantage Point layers active country rotation on a passive international baseMay 5, 2026 | finance.yahoo.comIs iShares' CORO a Buy After TSA Wealth Joined Other Institutional Investors in Purchasing the ETF?May 4, 2026 | finance.yahoo.comWealth Manager Takes New $55.6 Million Position in ETF, According to Latest SEC FilingApril 30, 2026 | aol.comAHobbs Wealth Buys a $7.3 Million Stake in CORO, BlackRock's Country Rotation ETFApril 28, 2026 | finance.yahoo.comEmbree Financial Purchased Shares Worth $13.1 Million in iShares' CORO. Is This ETF a Buy?April 27, 2026 | fool.comTriad Wealth Partners Builds Stake in iShares International Country Rotation Active ETF, According to Recent SEC FilingApril 17, 2026 | fool.comThis New $32 Million Stake Targets an Actively Managed International ETF With 31% ReturnsApril 14, 2026 | finance.yahoo.comIs the iShares CORO ETF a Buy After Kelly Financial Initiated a Position Worth Over $28.5 Million?April 14, 2026 | fool.comWhat to Know About an $8 Million Bet on CORO Targeting 31% Returns OverseasApril 9, 2026 | fool.comThis New $8 Million Bet on CORO Signals a Shift Beyond U.S. StocksApril 9, 2026 | fool.comBlackRock ETF Trust - iShares International Country Rotation Active ETFApril 1, 2026 | money.usnews.comDaily ETF Flows: CORO Makes AppearanceMarch 20, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeADME, BCE, CORO, and AST Company DescriptionsAptus Drawdown Managed Equity ETF BATS:ADME$55.77 -0.39 (-0.69%) As of 06/16/2026 04:10 PM EasternThe Aptus Drawdown Managed Equity ETF (ADME) is an exchange-traded fund that mostly invests in large cap equity. The fund is actively managed to select large-cap US stocks that exhibit positive fundamental and momentum characteristics combined with a downside hedge. ADME was launched on Jun 8, 2016 and is managed by Aptus.Asterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.BCE NYSE:BCE$23.80 -0.24 (-0.98%) Closing price 06/16/2026 03:59 PM EasternExtended Trading$23.82 +0.01 (+0.04%) As of 06/16/2026 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BCE Inc., a communications company, provides wireless, wireline, Internet, and television (TV) services to residential, business, and wholesale customers in Canada. The company operates through two segments, Bell Communication and Technology Services, and Bell Media. The Bell Communication and Technology Services segment provides wireless products and services including mobile data and voice plans and devices; wireline products and services comprising data, including internet access, internet protocol television, cloud-based services, and business solutions, as well as voice, and other communication services and products; and satellite TV and connectivity services for residential, small and medium-sized business, government, and large enterprise customers. This segment also buys and sells local telephone, long distance, and data and other services from or to resellers and other carriers; and operates consumer electronics retail stores. The Bell Media segment provides conventional TV, specialty TV, pay TV, streaming services, digital media services, radio broadcasting services, and out-of-home advertising services. BCE Inc. was founded in 1880 and is headquartered in Verdun, Canada.iShares International Country Rotation Active ETF NASDAQ:CORO$36.82 -0.15 (-0.41%) As of 06/16/2026 04:00 PM EasternThe iShares International Country Rotation Active ETF (CORO) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds, seeking long-term capital appreciation through investments in non-US companies. The fund targets nations with favorable economic outlooks by employing a country rotation strategy. CORO was launched on Dec 3, 2024 and is issued by BlackRock. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Gravity Check: Houston, SpaceX Has a Valuation Problem Okta’s AI Moment May Be Bigger Than Investors Realize Strategy’s Bitcoin Rally Has a Hidden Engine Is Lennar Finally Turning the Corner After Its Housing Slump? Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold? What's Behind the Social Media Controversy Surrounding IonQ? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
